Principal Financial Group’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $619K | Buy |
|
|||||
|
2025
Q2 | $61.7K | Buy |
|
|||||
|
2025
Q1 | $27.5K | Buy |
|
|||||
|
2024
Q4 | $23.2K | Sell |
|
|||||
|
2024
Q3 | $20.8K | Sell |
|
|||||
|
2024
Q2 | $21.5K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $52K | Sell |
|
|||||
|
2022
Q2 | $146K | Buy |
|
|||||
|
2022
Q1 | $132K | Sell |
|
|||||
|
2021
Q4 | $584K | Sell |
|
|||||
|
2021
Q3 | $1.55M | Sell |
|
|||||
|
2021
Q2 | $2.08M | Sell |
|
|||||
|
2021
Q1 | $1.94M | Buy |
|
|||||
|
2020
Q4 | $1.5M | Buy |
|
|||||
|
2020
Q3 | $337K | Buy |
|
|||||
|
2020
Q2 | $1.27M | Buy |
|
|||||
|
2020
Q1 | $231K | Buy |
|
|||||
|
2019
Q4 | $110K | Sell |
|
|||||
|
2019
Q3 | $111K | Buy |
|
|||||
|
2019
Q2 | $87K | Buy |
|
|||||
|
2019
Q1 | $92K | Sell |
|
|||||
|
2018
Q4 | $71K | Buy |
|